Related Experiment Videos

Drug sensitivity testing of human breast cancer

K M Tveit¹, L Ottestad

¹Norwegian Radium Hospital, Oslo, Norway.

Acta Oncologica (Stockholm, Sweden)

|January 1, 1990

Abstract:

A survey of drug sensitivity testing of human breast cancer is given. The purpose of sensitivity testing, the tumour material studied, and the various in vivo and in vitro assays that are being used are discussed. Moreover, examples of results obtained are presented.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends.

ESMO gastrointestinal oncology·2026

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin.

The pharmacogenomics journal·2015

Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.

Molecular oncology·2013

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.

British journal of cancer·2012

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.

British journal of cancer·2009

See all related articles